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ReportLoss-of-Function Mutation in
Tryptophan Hydroxylase-2 Identified
in Unipolar Major Depression
2004). Numerous studies have suggested associations
between various neuropsychiatric disorders and genes
that modulate central serotonergic neurotransmission,
such as the 5-HT transporter (SERT, 5-HTT) (Lesch et
al., 1996; Caspi et al., 2003; Murphy et al., 2003), 5-HT
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These four enzymes share considerable structural simi-
larity and require the samecofactors for function (Fitzpa-
trick, 1999; Jiang et al., 2000). In contrast to TPH1, whichSummary
controls most of peripheral 5-HT synthesis (Cote et al.,
2003; Walther et al., 2003), TPH2 was recently discov-Dysregulation of central serotonin neurotransmission
has been widely suspected as an important contribu- ered and found to be neuronal specific and predomi-
nantly expressed in brain serotonergic neurons originat-tor to major depression. Here, we identify a (G1463A)
single nucleotide polymorphism (SNP) in the rate-lim- ing from raphe nuclei (Walther et al., 2003; Patel et
al., 2004). We have previously identified a functionaliting enzyme of neuronal serotonin synthesis, human
tryptophanhydroxylase-2 (hTPH2). The functional SNP (C1473G) single nucleotide polymorphism (SNP) which
results in the replacement of proline with arginine atin hTPH2 replaces the highly conserved Arg441 with
His,which results in80% lossof function in serotonin position 447 in mouse Tph2 (Zhang et al., 2004). Expres-
sion of mutant Tph2 (P447R) in PC12 cells revealed anproduction when hTPH2 is expressed in PC12 cells.
Strikingly, SNP analysis in a cohort of 87 patients with 55% decrease in 5-HT levels as compared to wild-type
Tph2. Moreover BALB/cJ and DBA/2 inbred mice car-unipolar major depression revealed that nine patients
carried the mutant (1463A) allele, while among 219 rying the homozygous mutant (1473G) alleles showed
50%–70% reduction in the rate of synthesis of corticalcontrols, three subjects carried this mutation. In addi-
tion, this functional SNP was not found in a cohort of and striatal 5-HT accompanied by 40% reduction in
5-HT tissue content when compared to C57Bl/6 and60 bipolar disorder patients. Identification of a loss-
of-function mutation in hTPH2 suggests that defect in 129X1/SvJ inbred mice carrying homozygous wild-type
(1473C) alleles. Interestingly, these strains of mice dis-brain serotonin synthesis may represent an important
risk factor for unipolar major depression. play significantly different behaviors and responses to
antidepressants (Lucki et al., 2001). These observations
provided direct evidence for the fundamental role ofIntroduction
Tph2 in brain 5-HT synthesis (Zhang et al., 2004) and
raised the interesting possibility that similar mutationsThe neurotransmitter serotonin (5-hydroxytryptamine
[5-HT]) has been implicated in a variety of physiological in human TPH2 (hTPH2) may affect brain 5-HT homeo-
stasis in certain neuropsychiatric conditions.functions in both peripheral and central nervous sys-
tems (CNS) (Lucki, 1998; Veenstra-VanderWeele et al., Here we report the identification of a functional
(G1463A) SNP in hTPH2, which replaces a highly con-2000; Malhotra et al., 2004). Many neuropsychiatric
disorders, such as depression (Lesch, 2004; Malhotra servedArg441withHis and results in an80%reduction
in activity when expressed in cell culture systems. Fur-et al., 2004), schizophrenia (Veenstra-VanderWeele et
al., 2000), autism (Veenstra-VanderWeele and Cook, thermore, we identified nine subjects carrying this func-
tional SNP in a cohort of 87 unipolar major depression2004), aggression and suicidal behavior (Arango et al.,
2003), and attention-deficit/hyperactivity disorder (ADHD) patients. These data provide a potential molecular
mechanism for aberrant 5-HT function in neuropsychiat-(Gainetdinov et al., 1999; Quist and Kennedy, 2001), are
considered to be related to dysfunction in serotonergic ric disorders.
neurotransmission in the CNS. Therefore, the brain 5-HT
system is a major target for tricyclic antidepressants, Results
selective serotonin reuptake inhibitors (SSRIs), mono-
amine oxidase inhibitors (MAOIs), and psychostimulants In order to explore whether functional SNP(s) could be
(Lucki, 1998; Gainetdinov and Caron, 2003; Blier and identified in hTPH2, we screened 11 exons of hTPH2 by
Abbott, 2001; Gordon and Hen, 2004; Malhotra et al., sequence analysis in 48 genomic DNA samples ran-
domly selected from a cohort of 300 individuals from
a study of psychosocial and behavioral risk in lower*Correspondence: caron002@mc.duke.edu
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Figure 1. (G1463A) SNP in hTPH2 and Partial
Sequence Alignment of TH, PAH, TPH1,
and TPH2
(A) The (G1463A) polymorphism in hTPH2.
The G/A polymorphism is highlighted with an
arrowhead. Nucleotide numbers are shown
for the start and stop codons ofhTPH2 aswell
as the site of polymorphism. (B) Sequence
alignment of the C-terminal regions of tyro-
sine hydroxylase (TH), phenylalanine hydrox-
ylase (PAH), TPH1 and TPH2 in human (h),
mouse (m), and rat (r). The highly conserved
arginine residues are highlighted with an
arrowhead. Numbers indicate positions of
amino acids.
social-economical characteristic groups (Williams et al., FLAG or HA epitopes. As shown in Figure 2C, the R441H
mutant hTPH2 was able to form homo- (R441H-R441H)2003). Among these samples, one novel (G1463A) SNP
or hetero- (wt-R441H) oligomers to a similar extent asin the coding region of hTPH2 was identified, which
compared to wt hTPH2, suggesting that the R441H mu-replaced Arg441 (CGT) with His (CAT) (Figure 1A). Se-
tation does not affect dimerization of the subunits. Inquence alignment among TH, PAH, TPH1, and TPH2 in
fact, the equivalent R408W mutation in PAH has beenhuman, mouse, and rat revealed that Arg441 is highly
found to affect protein folding, causing a complete lossconserved among members of this family (Figure 1B).
of protein expression and enzymatic activity as com-Interestingly, an R408W mutation at the corresponding
pared to wt PAH (Pey et al., 2003). However, the arginineposition in PAH (Figure 1B) abolishes PAH enzyme activ-
to histidine mutation in hTPH2 did not markedly affectity and leads to phenylketonuria (PKU), the most severe
hTPH2 protein expression, at least when expressed inform of hyperphenylalaninemia. Furthermore, this R408W
PC12 cells (Figure 2A, lower panel), indicating that itmutation has been identified in 10% of the PKU pa-
may result in a perturbation that leads to amilder attenu-tients, representing the most prevalent pathogenic mu-
ation of function than the mutant PAH.tation in PAH (Scriver et al., 2003).
To analyze the functional consequence of the R441H
mutation in hTPH2 on 5-HT synthesis, we transfected
either hemagglutinin (HA)-tagged wild-type (wt) or
R441H mutant hTPH2 into pheochromocytoma (PC12)
cells and measured 5-HT levels as described (Xu et al.,
2000; Zhang et al., 2004). Previously, we established a
direct correlation between 5-HT levels measured in
PC12 cells transfected with Tph2 genetic variants and
the rate of 5-HT synthesis in the brains of inbred mice
carrying these Tph2 variants (Zhang et al., 2004). While
here we did not measure TPH2 enzyme activity directly,
we found that 5-HT levels in PC12 cells expressing the
R441H mutant were 80% lower as compared to PC12
cells expressing wt hTPH2 (Figure 2A), indicating a se-
vere loss of function in the ability of the mutant enzyme
Figure 2. Biochemical Properties of hTPH2 (R441H) Mutantto synthesize 5-HT. Because humans may carry hetero-
zygous (1463G/1463A) or homozygous (1463A/1463A) (A) 5-HT levels in PC12 cells expressing mutant R441H hTPH2 were
lower than those in PC12 cells expressing wt hTPH2 (n  8 experi-alleles and sinceoligomerization is required for the activ-
ments), whereas no differences in dopamine levels were observed.ity of this family of enzymes (Yang and Kaufman, 1994;
5-HT levels were normalized to the respective hTPH2 expressionFitzpatrick, 1999), we tested whether the R441H mutant
levels (mutant enzyme expression was75% of wt levels). (B) Addi-
could exert a dominant-negative effect and/or affect tive, not dominant-negative, effect of R441H hTPH2. 5-HT levels
oligomerization of hTPH2.We firstmeasured 5-HT levels were measured in PC12 cells transfected with plasmids expressing
wt (10 g), wt (5 g)  R441H (5 g), or R441H (10 g) (n  4in PC12 cells transfected with plasmids encoding wt
experiments). (C) Immunoprecipitation of hTPH2. PC12 cells trans-hTPH2, R441H mutant hTPH2, or the combination of
fected with wt or mutant R441H hTPH2 were subjected to immuno-both plasmids. These experiments revealed an additive,
precipitation (IP) with anti()-FLAG antibody and immunoblotted (IB)not dominant-negative, effect of the R441H mutant on
with anti()-HA antibody conjugated to horse radish peroxidase
5-HT synthesis (Figure 2B).We then performed immuno- (HRP). (All data are presented as means  SEMs. Statistical signifi-
precipitation studies in PC12 cells expressing wt-wt, cance of all data presented is analyzed by Student’s t test: ***p 
0.001.)wt-R441H, or R441H-R441H hTPH2 tagged with either
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seven of them had a family history of mental illness or
drug and alcohol abuse, six had suicidal ideation or
attempt, four had generalized anxiety symptoms, and
interestingly, seven patients exhibited lack of respon-
siveness to SSRI, while the other two patients were
responsive only to highest doses of SSRI (Table 1). The
three control subjects carrying the 1463A allele were
not diagnosed as having unipolar major depression ac-
cording to the criteria of the Diagnostic and Statistical
Manual ofMental Disorders (DSM-IV), but theydisplayed
clinical symptoms of comorbid conditions. One of the
three control subjects carrying homozygous mutant
(1463A) alleles had generalized anxiety symptoms, while
Figure 3. Allele-Specific Genotyping of (G1463A) SNP in hTPH2 the other two carrying heterozygous (1463G/1463A) al-
(A) The (1463G) or (1463A) allele in hTPH2. Positive control primers leles had mild depression and a family history of mental
and allele-specific primers for genotyping are shown as black and illness or drug and alcohol abuse (Table 1), suggesting
gray arrows, respectively. (B) Genotyping of (G1463A) polymorphism
a potentially higher susceptibility for certain neuropsy-in human genomicDNA samples and cloning vectors of partial geno-
chiatric disorders in the presence of the mutant (1463A)mic DNA carrying either (1463G) or (1463A) allele. PCR products for
allele.positive control (492 bp) and allele-specific products (294 bp) are
indicated with arrowheads.
Discussion
In this study, we report the identification of a mutationBased on the studies in PC12 cells, we then searched
for this functional (1463A) allele in human populations in human TPH2 that results in 80% loss of function in
the activity of the enzyme. Moreover, nine subjects fromwith 5-HT-related psychiatric disorders. First, we estab-
lished a PCR-based genotyping method using a modi- a cohort of 87 unipolar major depression patients were
found to carry the mutant (1463A) allele. These findingsfied amplification refractory mutation system (ARMS)-
PCR (Ye et al., 2001) with one allele-specific primer and suggest that deficiency in brain 5-HT synthesis may be
an important risk factor for unipolar major depression.two positive control primers flanking the site of the
(G1463A) SNP (Figure 3A) (Zhang et al., 2004). As shown We previously characterized a functional (C1473G)
SNP in mouse Tph2 that exhibited an 55% reductionin Figure 3B, only G-allele-specific primers gave rise to
an allele-specific PCR product (294 bp) in a genomic in activity when expressed in PC12 cells and an 50%
decrease in the rate of brain 5-HT synthesis and tissueDNA sample carrying homozygous wt 1463G/1463G al-
leles, while both G- and A-allele-specific PCR products content in mice carrying the mutant allele (Zhang et al.,
2004). The highly conserved Pro residue correspondingwere detected in a genomic DNA sample carrying het-
erozygous 1463G/1463A alleles. To further validate this to this functional (C1473G) SNP in mice is Pro449 in
human TPH2, which is in close proximity to the (G1463A)allele-specific PCR genotyping approach, we amplified
genomic DNA using the two positive control primers SNP (Arg441) reported in the present study, suggesting
that this region of hTPH2 is critical for enzyme function.mentioned above to clone the PCR fragment (492 bp)
into a cloning vector and then confirmed by sequence Importantly, when the R441H mutant hTPH2 was ex-
pressed in PC12 cells, 5-HT levels were reduced byanalysis. Cloning vectors carrying either the (1463G) or
(1463A) allele were then used as templates to confirm 80% as compared to wt hTPH2, indicating a more
severe loss-of-function phenotype as compared to thethe specificity of the genotyping method (Figure 3B).
We next used ARMS-PCR to screen a cohort of unipo- mouse Tph2 (P447R) mutant. Therefore, this human
R441H mutation in hTPH2 may exert an even more pro-larmajor depression patients (n 87), a cohort of bipolar
disorder patients (n 60), and control subjects (n 219) found effect on brain 5-HT homeostasis.
Unipolar major depression is a brain disorder withfor the (G1463A) SNP in hTPH2. Using this approach, we
identified nine unipolar major depression patients and 2%–19% population prevalence and 40%–70% herita-
bility with complex, polygenic, and epistatic genetic fac-three control subjects who carried the mutant (1463A)
allele. No carriers of the mutant allele were found among tors (Lesch, 2004). Previous linkage studies have pro-
vided evidence that there is a sex-specific dispositionbipolar disorder patients (Table 1). The frequency of
the mutant (1463A) allele in unipolar major depression locus for major depression on chromosome 12q22–
12q23.2, confirming chromosome 12q as one of the can-patients versus control subjects was statistically signifi-
cant (2  13.31, p  0.001). No statistical difference in didate regions for neuropsychiatric disorder susceptibil-
ity (Abkevich et al., 2003). Human TPH2 is located onthe frequency of this mutant allele was present between
bipolar disorder patients and control subjects. Geno- chromosome 12q21.1 and, as we report here, a severe
loss-of-function R441H mutation in hTPH2 has beentypes of samples identified carrying the (1463A) allele
and additional samples from the control subjects (n  identified in 9 out of 87 unipolar major depression pa-
tients tested. Our results that 78 unipolar major depres-24) were then confirmed by sequence analysis of Exon
XI of hTPH2. Among the nine unipolar major depression sion patients in this study carry wt (1463G) alleles are
not surprising, because depression is heterogeneous inpatients identified, six patients carried heterozygous
(1463G/1463A) alleles and three patients carried homo- origin and genes other than hTPH2 or other functional
SNP(s) in hTPH2 may also contribute to vulnerability tozygous (1463A/1463A) alleles (Table 1). Furthermore,
Neuron
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Table 1. Summary of Subjects Carrying Functional (G1463A) SNP in hTPH2
Unipolar Major Family SSRI
Depression Patients Patient I.D. Sex Age Allele History Suicidality Anxiety Response Note
n  87 1202 F 72 A/A     Sertraline 200 mg
1294 M 80 G/A    
1496 M 74 A/A     Sertraline 100 mg
1745 M 71 G/A    
1747 M 82 G/A    
1839 F 69 G/A    
1851 F 65 G/A    
1902 F 77 A/A    
1975 M 64 G/A    
Control Subjects
n  219 1174 F 76 A/A  
1541 F 80 G/A   mild depression
1996 F 75 G/A   mild depression
Family history: family history for mental illness, drug, and alcohol abuse. Suicidality: suicidal ideation or attempt. Anxiety: three or more anxiety
symptoms. All patients listed above were Caucasians, except subject 1541, who was African American. The mutant (1463A) allele was not
found in a cohort of 60 bipolar disorder patients.
unipolar major depression. In fact, emerging evidence 400 mutations in the closely related enzyme PAH that
cause various degrees of hyperphenylalaninemia, andindicates that genetic variance plays a critical role in
different clinical responses to psychotropic drugs (Mal- over 300 mutations identified are missense mutations
in the coding regions (Scriver et al., 2003). In fact, wehotra et al., 2004). For example, a growing number of
studies have suggested a relationship, although with recently found twoadditional SNPs in the coding regions
of hTPH2 that are currently under investigation (dataconflicting results, between a polymorphism in the pro-
moter region of SERT (Lesch et al., 1996) and efficacy not shown).
In conclusion, our present and previous biochemicalof SSRI to treat depression (Malhotra et al., 2004). In-
triguingly, in our study, reduced responsiveness to SSRI studies in human and mice (Zhang et al., 2004) provide
a potential molecular mechanism underlying dysfunc-in unipolar major depression patients was found in sub-
jects carrying the functional (G1463A) SNP in hTPH2, tion in 5-HT neurotransmission in the brain. Clearly, fur-
ther large-scale genetic studies are needed to confirmsuggesting a role of brain 5-HT synthesis in the efficacy
of SSRI treatment. It will be also important in future these observations and to investigate in detail the inheri-
tance and penetrance of this functional (G1463A) SNPstudies to examine whether loss-of-function mutations
in hTPH2 may play a role in the paradoxical adverse in hTPH2 in unipolar major depression. Furthermore,
detailed kinetic and biochemical characterization of theeffects in response to SSRI treatment, such as suicid-
ality (March et al., 2004) and SSRI-exacerbated mania mutant enzyme as well as direct measurements of brain
5-HT status in affected subjects will ultimately beand psychosis (Malhotra et al., 2004).
The three control subjects carrying the (1463A) allele needed. It will also be of interest to test how this muta-
tion may interact with other genetic alterations pre-in hTPH2 were not included in the cohort of unipolar
major depression patients based on criteria of DSM-IV viously associated with depression. Finally, it will be
worth exploring the presence of this and other functionaldiagnosis. However, the fact that these subjects had
generalized anxiety symptoms or mild depression and mutations of hTPH2 in other neuropsychiatric condi-
tions, such as generalized anxiety disorder, schizophre-a family history of mental illness or drug and alcohol
abuse further underscores the complexity and polyge- nia, suicidality, autism, ADHD, and drug abuse.
netic nature of neuropsychiatric disorders. It is possible
that functional SNPs in hTPH2, including this (G1463A)
Experimental Procedures
SNP, may be present as an important predisposing fac-
tor in the pathophysiology of several neuropsychiatric Research Samples
Subjects in the original cohort of300 healthy adultswere evaluateddisorders. It is also noteworthy that the functional
to rule out neuropsychiatric disorders. They were recruited from the(G1463A) SNP was not found in a small cohort of bipolar
community for participating in a study of psychosocial and behav-disorder patients in this study. A recent genetic associa-
ioral risk in lower social-economical characteristic groups (Williamstion study using a bipolar disorder French-Canadian
et al., 2003). Subjects investigated in detail in this study were partici-
pedigree has identified SNPs in noncoding regions of pants in the NIMH sponsored Conte Center for the Neuroscience
hTPH2, suggesting a potential role of hTPH2 in bipolar of Depression at Duke University. Subjects gave informed consent
prior to entry into the study. The study was approved by the Institu-disorder (Harvey et al., 2004). Therefore, further studies
tional Review Board. The interview procedures used a structuredwill be needed to elucidate the relationship between
interviewDukeDepression Evaluation Schedule (DDESE). This inter-hTPH2 function and bipolar disorder.
view uses the Diagnostic Interview Schedule (DIS) (Bosworth et al.,Although (G1463A) is the first functional SNP identified
2002). At baseline enrollment, 87 unrelated subjects had a DSM-IV
in human TPH2, it is likely that additional functional diagnosis of unipolar major depression and were 60 years of age
SNP(s) could be found in hTPH2. In support of this idea, or older; they did not have to be currently depressed to participate
in this study. These subjects were not diagnosed with any othernumerous studies have shown that there are more than
TPH2 Mutation in Depression
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psychiatric disorders. Sixty additional subjects had a DSM-IV diag- Blier, P., and Abbott, F.V. (2001). Putative mechanisms of action of
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ing unipolar major depression, bipolar disorder, or any other major Bonasera, S.J., and Tecott, L.H. (2000). Mouse models of serotonin
neuropsychiatric disorders or substance abuse. Among the total receptor function: toward a genetic dissection of serotonin systems.
366 subjects tested in this study, 331 were Caucasians, 28 were Pharmacol. Ther. 88, 133–142.
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(2002). Time-to-remission from geriatric depression: psychosocialwas extracted.
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and Caron, M.G. (1999). Role of serotonin in the paradoxical calmingallele. The PCR reactions were carried out with primers for positive
effect of psychostimulants on hyperactivity. Science 283, 397–401.control (hOuter/Forward [5	-ATGTGTGAAAGCCTTTGACCCAAAG
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